Aldrich Capital Partners
Aldrich Capital Partners describes itself as a growth-oriented equity firm formed by investors and operators with entrepreneurial backgrounds. Its stated approach combines growth capital with strategic, board-level, and operational support for founder-run companies.
What stands out about Aldrich Capital Partners
Aldrich Capital Partners publicly describes a strategy focused on founder-run, capital-efficient companies ready to accelerate growth. Its stated technology-sector focus includes healthcare IT, financial technology, and application software, while its Fund I materials identify North American lower-middle-market companies and both control and minority growth-equity investments.[1][2][3][7][14]
What does Aldrich Capital Partners invest in?
Aldrich Capital Partners is a growth-oriented equity firm founded in 2014 by investors and operators with entrepreneurial backgrounds. The firm describes its role as being the “entrepreneurs behind the entrepreneur.”
ACP states that it partners with founder-run companies that have built successful businesses in a capital-efficient way and are ready to accelerate growth. Its publicly described support includes liquidity, strategic guidance, additional capital for expansion or acquisitions, senior-executive recruitment, board building, and operational assistance.[1][2][3]
ACP describes its strategy as providing growth equity to founder-run businesses prepared to scale. Its Fund I strategy included both control and minority growth-equity investments.
The firm also states that it can provide liquidity while supporting expansion, acquisitions, senior leadership recruitment, board development, transaction execution, and post-merger integration.[1][2][3]
Owners evaluating a financial buyer can compare the offer with independent valuation analysis, understand how acquirers approach transactions through Auxo’s buy-side M&A process guide, and consider whether a full or partial sale best fits their objectives.
What should a business owner evaluate before considering a transaction with Aldrich Capital Partners?
Owners evaluating a sale or growth-capital partnership should clarify whether the proposed investment would be control, minority, or another structure, because ACP’s Fund I materials document both control and minority investments. They should also confirm rollover equity, management incentives, board rights, founder roles, follow-on capital for acquisitions or organic expansion, and the operating resources assigned to the company.
ACP publicly describes support for liquidity, senior-executive recruitment, board building, outsourced M&A execution, and post-merger integration. Owners should ask how those capabilities would apply to the proposed transaction and which legal entity would make the investment.[2][3][12][13]
What current revenue, EBITDA, enterprise-value, growth-rate, and ownership criteria determine investment eligibility
Does ACP generally seek control, minority, or flexible positions by situation
How are rollover equity, management incentives, board rights, and founder roles structured
What companies does Aldrich Capital Partners target?
ACP describes its target companies as founder-run businesses that have built successful companies in a capital-efficient way and are ready to accelerate growth. Fund I materials identify North American-based lower-middle-market companies as the general target and state that the fund made both control and minority investments.
The official investment-approach page does not publish a universal current revenue, EBITDA, enterprise-value, minimum-check, ownership-percentage, or investment-horizon threshold.[1][2][3]
ACP identifies healthcare IT, financial technology, and application software as principal technology-sector areas. Its broader public positioning also refers to technology-driven companies.[2]
ACP’s debut institutional fund focused generally on North American-based lower-middle-market companies. Its official contact page lists offices in McLean, Virginia; Los Altos, California; and Hyderabad, India.[2][4]
ACP states that it can provide additional capital for expansion or acquisitions and act as an outsourced M&A team covering target prioritization, transaction structuring and execution, and post-merger integration.
A 2025 announcement described a $107 million recapitalization with Persivia and stated that ACP intended to help the company scale through targeted acquisitions and partnerships.[3][5]
Publicly documented investment examples include ProcessMaker, TimeDoc Health, Compliancy Group, OnePlan Solutions, SpinSci, and Persivia. The official portfolio page identifies sector filters and a portfolio-company section but does not display identifiable company names in the accessible page content; the names above are drawn from separate official transaction announcements.[5][6][8][9][10][11][14]
- ACP announced a $107 million recapitalization with Persivia on May 9, 2025; the announcement stated that ACP intended to support growth through targeted acquisitions and partnerships.
- SpinSci announced a $53 million majority investment from ACP on December 11, 2024.
- ACP announced the sale of Paymerang to Corpay on May 9, 2024; the announcement stated that ACP had acquired Paymerang in 2018.
- ACP announced a strategic investment in OnePlan Solutions on July 12, 2023 to support expansion, product development, and global market reach.
- TimeDoc Health announced a $48.5 million Series B round from ACP on March 22, 2022 and stated that ACP joined its board alongside an existing investor.
- ACP announced a $45 million investment for a majority stake in ProcessMaker on February 12, 2021.
What is not clear from Aldrich Capital Partners's public investment criteria?
The Aldrich Capital Partners homepage reports AUM and portfolio-company metrics but does not state a firm-level SEC, state investment-adviser, broker-dealer, or other regulatory registration number or status.
The official investment-approach page does not publish a universal current revenue, EBITDA, enterprise-value, minimum-check, ownership-percentage, or investment-horizon threshold.
The Paymerang sale announcement does not disclose transaction consideration, ownership percentage sold, financing terms, or the final closing date.[1][3][7]
Questions to ask when evaluating Aldrich Capital Partners as a buyer or investment partner
What current revenue, EBITDA, enterprise-value, growth-rate, and ownership criteria determine investment eligibility?
Does ACP generally seek control, minority, or flexible positions by situation?
How are rollover equity, management incentives, board rights, and founder roles structured?
What follow-on capital is available for acquisitions and organic expansion?
Which operating resources are assigned to a new portfolio company, and at what cost?
What is the expected investment horizon and exit-planning process?
Which legal entity will make the investment, and what firm-level regulatory status and compliance framework apply to the proposed transaction?
Sources & research notes
- Official website / firm overview
- Official website / firm overview
- Services / capabilities
- Geography / market coverage
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- Transaction / portfolio evidence
- SEC filing / regulatory record
- SEC filing / regulatory record
- Public disclosure information
How this profile was researched
Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.
Independent research profile
This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.
Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.
Broker-dealer and securities disclosure
Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.
Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.
Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.
Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.